Transplant-related bronchiolitis obliterans

This Phase 3 trial tested whether adding inhaled liposomal cyclosporine A to standard care can improve lung function in 169 double lung transplant patients with chronic rejection. Participants inhaled the drug twice daily for 48 weeks. The main goal was to see if it slowed the de…

This Phase 3 trial tested whether adding inhaled liposomal cyclosporine A to standard care helps single lung transplant patients with chronic lung rejection. 62 adults who had a single lung transplant at least a year earlier and had signs of chronic rejection took part. The study…

This study reviews the medical records of about 284 adults who developed chronic lung allograft dysfunction with bronchiolitis obliterans syndrome (CLAD-BOS) after a lung transplant. Researchers will track how lung function, measured by FEV1, changes each year after diagnosis. Th…